As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: February 1, 2012
by Cardiff University
Specific genes known to be one of the causes of a rare type of Alzheimer’s, which runs in families, are unlikely to contribute to the more common form of the disease, University scientists have uncovered.
A team of scientists from the University’s MRC Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute examined three genes APP, PSEN1and PSEN2 known to cause uncommon early onset forms of Alzheimer’s.
The team sought to establish whether common genetic variation within these genes confer risk to the more frequent form of Alzheimer’s, which occurs later in life in people aged over 65.
Dr Amy Gerrish, School of Medicine, who led the research, said: “We tested single-nucleotide polymorphisms (SNPs) at APP, PSEN1, PSEN2 as well as MAPT, a gene linked to Alzheimer’s pathology for association with common Alzheimer’s in a large case-control sample consisting of 3,940 cases and 13,373 controls.
“The study provides evidence that common variation within APP, PSEN1and PSEN2 genes, which cause early-onset Alzheimer’s, as well as MAPTis unlikely to make a strong contribution to common Alzheimer’s disease.”
The findings, published in the Journal of Alzheimer’s Disease, add to the growing body of evidence which is helping to piece together the genetic, environmental and social factors which contribute to a person’s risk of developing Alzheimer’s.
Previous Cardiff research has identified an additional eight new genes – bringing the total number of genes that increase the risk of developing Alzheimer’s to ten.
The discovery of these new genes has enabled the team to identify differences in the responses of people with Alzheimer’s disease.
Specifically, they are able to implicate a number of risk factors including: a sufferer’s immune system, the ways the brain processes cholesterol and lipids and for the first time, a process called endocytosis – which, in normal healthy brains removes toxic amyloid-beta protein from the brain.
Dr Gerrish added: “What our research suggests is that the cause of common Alzheimer’s disease is more complex than early onset Alzheimer’s, involving multiple risk genes, environmental and lifestyle factors.
“This study, plus our previous studies, means we are beginning to piece together the jigsaw and gain new understanding. We still have a long way to go – but the jigsaw is beginning to come together.”
Picture Source: Dr. Dunckley, M.D.
For the first time, scientists have produced evidence in living humans that the protein tau, which mars the brain in Alzheimer’s disease, spreads from neuron to neuron. Although such movement wasn’t directly observed, the finding...
When the average person goes to the doctor, shows up at the ER, or enters the hospital, the possibility of controlling what happens next is minimal. We put ourselves...
According to the Alzheimer’s Society of Canada, 72% of Canadians living with Alzheimer’s disease are women. Is that because of their biological sex at birth? Does it have to do with the fact that...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.